Stocks and Investing Stocks and Investing
Wed, December 19, 2018
Tue, December 18, 2018

Matt Miksic Initiated (BSX) at Buy and Held Target at $42 on, Dec 18th, 2018


Published on 2024-10-26 11:20:00 - WOPRAI, Matt Miksic
  Print publication without navigation


Matt Miksic of Credit Suisse, Initiated "Boston Scientific Corporation" (BSX) at Buy and Held Target at $42 on, Dec 18th, 2018.

Matt has made no other calls on BSX in the last 4 months.



There are 6 other peers that have a rating on BSX. Out of the 6 peers that are also analyzing BSX, 0 agree with Matt's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Matt


  • John Eade of "Argus Research" Maintained at Strong Buy with Increased Target to $43 on, Friday, October 26th, 2018
  • Jason Mills of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $42 on, Thursday, October 25th, 2018
  • Travis Steed of "Barclays" Initiated at Buy and Held Target at $43 on, Tuesday, October 16th, 2018
  • Cecilia Furlong of "Morgan Stanley" Maintained at Buy with Increased Target to $48 on, Tuesday, October 2nd, 2018
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $42 on, Monday, September 17th, 2018
  • Jayson Bedford of "Raymond James" Maintained at Strong Buy with Increased Target to $41 on, Tuesday, September 4th, 2018
Contributing Sources